期刊文献+

Survivin表达与结肠癌组织分化、TNM分期的关系 被引量:4

Correlationship Between Tumor Tissue Survivin Expression and Degree of Histologic Differentiation as well as TNM Stage in Patients with Colonic Carcinoma
下载PDF
导出
摘要 目的:研究探讨Survivin表达与结肠癌组织分化、TNM分期的关系。方法:采用免疫组化方法检测117例结肠癌患者手术病理标本中Survivin的表达情况,并根据患者组织分化程度、TNM分期分类统计Survivin的表达情况。结果:高分化结肠癌标本Survivin表达阳性率为51.0%,明显低于中低分化结肠癌标本的100%(P<0.05)。Ⅰ、Ⅱ期结肠癌标本Survivin表达阳性率为59.1%,明显低于Ⅲ、Ⅳ期结肠癌标本的98.0%(P<0.05)。结论:Survivin的表达阳性率与结肠癌的分化程度、TNM分期密切相关,临床可通过检测结肠癌病理标本中Survivin的表达水平,作为判断预后的生物学指标。 Objective To study the expression of survivin in colon-carcinoma tissue and its correlation with degree of tumor differentiation and TNM stage in patients with colonic carcinoma. Methods Immunohistochemistry method was applied to detect the survivin expression in surgical specimens from 117 patients with colonic carcinoma,and the results were analyzed statistically with reference to the degree of tumor differentiation and TNM stage. Results The positive rate of survivin expression in well differentiated colon carcinoma specimens was 51.0%,being significantly lower than that in poorly differentiated specimens (100%,P0.05). On the other hand,the positive rate of survivin in colon carcinoma specimens of TNM and Ⅱ stages was 59.1%,also significantly lower than that of Ⅲ,Ⅳ stage specimens (98.0%,P0.05). Conclusion The positive rate of survivin expression was closely related with degree of tumor differentiation and TNM stage. Survivin expression in colon carcinoma specimens might be used as an indicator for prognosis prediction.
出处 《放射免疫学杂志》 CAS 2010年第2期188-189,共2页 Journal of Radioimmanology
关键词 结肠癌 生存素 组织分化 TNM分期 colon carcinoma survivin histologic differentiation TNM stage
  • 相关文献

参考文献8

二级参考文献54

共引文献159

同被引文献60

  • 1江志敏,姚和瑞,詹俊,谢德荣,李海刚.Survivin在结肠癌组织中的表达及意义[J].癌症,2004,23(z1):1414-1417. 被引量:13
  • 2谷化平,尚培中,张正猛.Survivin和p63基因蛋白在食管鳞状细胞癌的表达及临床意义[J].山西医科大学学报,2005,36(4):436-439. 被引量:9
  • 3王蓉,邓明高,杨国嵘,刘雄昌,吴德明,张煦.Survivin、MMP-9在大肠腺瘤癌变过程中的表达及其临床意义[J].中国老年学杂志,2007,27(5):458-461. 被引量:6
  • 4郑树,黄彦钦.NCCN结肠癌临床诊疗指南解读[J].实用肿瘤杂志,2007,22(3):206-207. 被引量:35
  • 5Tsuruma T,Iwayama Y,Ohmura T,et al.Clinical and immunological evaluation of anti-apoptosis protein,survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer[J].J Transl Med,2008,6:24. 被引量:1
  • 6Honma I,Kitamura H,Torigoe T,et al.Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer[J].Cancer Immunol Immunother,2009,58(11):1801-1807. 被引量:1
  • 7Kim HS,Kim CH,Park MY,et al.Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model[J].Immunol Lett,2010,131(1):73-80. 被引量:1
  • 8Shi X,Wang D,Ding K,et al.GDP366,a novel small molecule dual inhibitor of survivin and Op18,induces cell growth inhibition,cellular senescence and mitotic catastrophe in human cancer cells[J].Cancer Biol Ther.2010,9(8):640-650. 被引量:1
  • 9Horisberger K,Erben P,Strbel P,et al.Annexin and survivin in locally advanced rectal cancer:indicators of resistance to preoperative chemoradiotherapy[J] ?Onkologie,2010,33(8-9):439-444. 被引量:1
  • 10Aklilu M,Kindler HL,Donehower RC,et al.Phase II study of flavopiridol in patients with advanced colorectal cancer[J].Ann Oncol,2003,14 (8):1270-1273. 被引量:1

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部